SOURCE: Advantis Corporation

Advantis Corporation

April 11, 2016 09:26 ET

Advantis Corp. Acquires Ownership Stake in Sequence Therapy, LLC, $500,000 Revenue Expected; Additionally Inks New Deal and Expands LipMedRx Distribution

SANTA ANA, CA--(Marketwired - Apr 11, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced it has acquired an ownership stake in Sequence Therapy, LLC. Advantis Corp. CEO, Chris Swartz, also announced that a new deal has been signed to secure the rights to use a patented packaging technology for cannabis, nutraceutical, and pharmaceutical products; Swartz also stated that several new retailers are selling LipMedRx lip balm.

Advantis Corp. recently acquired a 25% stake in pain management and physical therapy company, Sequence Therapy, LLC. Sequence Therapy currently earns $500,000/ year in revenue from its current practice, and income is expected to expand exponentially with the addition of the app-based revenue source. The company is currently working to provide its license-based digital application to physicians, chiropractors, senior living centers, gyms, and physical therapists. Advantis CEO, Chris Swartz, was excited to share this development, saying, "This technology allows physicians to prescribe a set of exercises through Sequence Therapy's digital application, and alter the sequence and set of exercises based on the patients need," Swartz said. "This requires that patients go back to their prescriber to get new exercises as there therapy evolves." Swartz related the potential revenue that will be created by licensing this application and enhancing its usefulness over time. "I am excited that Advantis will be the sole distributor of this technology and we are already in negotiations with large organizations that are excited to use this technology as soon as possible; and will produce long term results for millions of people suffering from chronic pain." This app-based pain management solution has been tested on over 15,000 patient sessions over the past 10 years.

Swartz also spoke about a deal that was just signed that will allow Advantis to issue a sublicense to Natural Elements in order to package their own privately labeled cannabis products. "This deal is a step toward showcasing the highly specialized and lab-tested products that Natural Elements provides to its members," Swartz said. The company specializes in packaging medical cannabis and pharmaceutical products within a hermetically sealed container that preserves freshness of the products. Each container will have a proprietary label affixed to identify the product and/or patient. Natural Elements currently has over 500 members and 20 member cooperatives that it provides its proprietary goods to. Advantis has expanded its distribution of the LipMedRx lip balm product that it is the exclusive distributor for. There are now thirty-four Southern California liquor stores, gas stations and 7-11 proprietors that are selling the lip balm at their retail establishments. "In addition to selling the lip balm globally on Amazon, we are continuing negotiations with major retail establishments," Swartz said. "The initial response has been overwhelming, and we will continue to widen our distribution channels." Revenue figures from the initial sales of the product will be reported in the next quarterly report; since Advantis only began distributing the product within the last 30 days, no significant revenue will be expected until the following quarter. Swartz took a moment to comment on overall state of business and thank investors for their loyalty. "This management team has done a fantastic job of setting the table," Swartz commented. "Several partnership and distribution agreements have laid the groundwork toward a diversified business model that is starting to turn potential energy into kinetic. The foundation has been established, and it is now time to execute. There are still several developments to be made, especially in the way of the cannabis business in on other states, however, the business process is in motion. I am thankful for the loyalty and patience our shareholders have shown during this regenerative time in Advantis' business cycle."

ABOUT Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes domestic and international partnerships with businesses that develop and sell proprietary pain management, and consumer products and services. Product lines for consumer health care, music and entertainment sectors are in development.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

Contact Information

  • For further information, contact:
    Media Relations Contact
    Name: Woo Kim
    Director
    Organization: Advantis Corporation
    Phone: 800-891-0508
    Address: 6 Hutton Centre Dr. Santa Ana, CA 92707
    E-mail: info@advantiscorp.com